What's Happening?
A clinical trial conducted by researchers at Mass General Brigham has demonstrated that the drug solriamfetol (Sunosi) can significantly improve alertness in early morning shift workers suffering from shift work disorder. This condition, which affects
individuals working outside the typical 9 to 5 schedule, is characterized by disrupted sleep patterns and persistent daytime sleepiness. The study, published in NEJM Evidence, involved 78 participants who were randomly assigned to receive either solriamfetol or a placebo over a four-week period. Results showed that those taking solriamfetol experienced less sleepiness and improved performance during simulated work hours. The drug, already approved for treating excessive sleepiness in conditions like obstructive sleep apnea and narcolepsy, was found to promote alertness without significantly disrupting later sleep.
Why It's Important?
The findings of this study are significant as they address a major gap in the treatment of shift work disorder, particularly for early morning shift workers who have not been widely studied. Shift work disorder poses serious health and safety risks, including reduced mental sharpness, lower productivity, and increased risk of accidents. By improving alertness and performance, solriamfetol could enhance the quality of life and safety for millions of workers who start their day when most people are still asleep. This research highlights the potential for solriamfetol to be a valuable therapeutic option for a large segment of the workforce, potentially leading to broader approval for treating shift work disorder.
What's Next?
The researchers emphasize the need for further studies to understand the long-term effects of solriamfetol on early morning shift workers. A follow-up clinical trial is being planned to study the drug's effects on overnight shift workers, which could support broader approval for its use in treating shift work disorder. This ongoing research is crucial for developing comprehensive treatment strategies for shift workers, who play an essential role in society but often face significant biological challenges due to their work schedules.
